Published on: November 30, 2017 at 10:00AM
Condition: Prostate Cancer
Interventions: Drug: Docetaxel; Drug: Degarelix; Drug: Bicalutamide
Sponsors: University of Wisconsin, Madison; United States Department of Defense; National Cancer Institute (NCI)
Not yet recruiting
http://ift.tt/2i6pFX7
No comments:
Post a Comment